Understanding drug uptake and binding within targeted disease micro‐environments in patients: a new tool for translational medicine-Reference-Cited by-同舟云学术

Understanding drug uptake and binding within targeted disease micro‐environments in patients: a new tool for translational medicine

Published:2012-05-31 Issue:1 Volume:1 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical and Translational Medicine

Author:

Marko‐Varga György¹²,Végvári Ákos¹,Rezeli Melinda¹,Prikk Kaiu³,Ross Peeter³,Dahlbäck Magnus⁴,Edula Goutham⁴,Sepper Ruth³,Fehniger Thomas E¹³

Affiliation:

1. Clinical Protein Science & ImagingBiomedical CenterDept. of Measurement Technology and Industrial Electrical EngineeringLund UniversityBMC C13SE‐221 84LundSweden

2. First Department of SurgeryTokyo Medical University6‐7‐1 Nishishinjiku Shinjiku‐ku160‐0023TokyoJapan

3. Institute of Clinical MedicineTallinn University of TechnologyAkadeemia tee 1512618TallinnEstonia

4. AstraZeneca R&D LundLundSweden

Funder

Knut och Alice Wallenbergs Stiftelse

Crafoordska Stiftelsen

Eesti Teadusfondi

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1186/2001-1326-1-8

Reference23 articles.

1. VegvariA RezeliM DomeB FehnigerTE Marko‐VargaG: Translation Science for Targeted Personalized Medicine Treatments. InSelected Presentations from the 2011 Sino‐American Symposium on Clinical and Translational Medicine.Edited by SandersS.Washington DC: Science/AAAS2011:36–37. [Sanders S (Series Editor).

2. Personalized Medicine and Proteomics: Lessons from Non-Small Cell Lung Cancer

3. AusbornNL LeQT BradleyJD ChoyH DickerAP SahaD SimkoJ StoryMD TorossianA LuB: Molecular Profiling to Optimize Treatment in Non‐Small Cell Lung Cancer: A Review of Potential Molecular Targets for Radiation Therapy by the Translational Research Program of the Radiation Therapy Oncology Group.Int J Radiat Oncol Biol Phys2012.

4. Proteomic Biomarkers for Acute Interstitial Lung Disease in Gefitinib-Treated Japanese Lung Cancer Patients

5. Translational Discoveries, Personalized Medicine, and Living Biobanks of the Future;Lisanti MP;Am J Pathol,2012

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A radionuclide-labeled nanomedicine for STING pathway activation- and oxygenation-augmented orthotopic cancer radioisotope-immunotherapy;Chemical Engineering Journal;2024-03

2. Imaging drug delivery to the lungs: Methods and applications in oncology;Advanced Drug Delivery Reviews;2023-01

3. THE SPACE DIMENSION AT THE MICRO LEVEL: MASS SPECTROMETRY IMAGING OF DRUGS IN TISSUES;Mass Spectrometry Reviews;2020-06-05

4. Clinical protein science in translational medicine targeting malignant melanoma;Cell Biology and Toxicology;2019-03-21

5. Radionuclide Imaging-Guided Chemo-Radioisotope Synergistic Therapy Using a 131I-Labeled Polydopamine Multifunctional Nanocarrier;Molecular Therapy;2018-05